Actively Recruiting

Phase 4
Age: 19Years - 80Years
All Genders
NCT04432220

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

Led by Yonsei University · Updated on 2023-02-06

840

Participants Needed

1

Research Sites

426 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

There has no evidence for the anticoagulation in patients who had undergone catheter ablation of atrial fibrillation, and has maintained sinus rhythm for more than 1 year. However, anticoagulation can increase the risk of bleeding, the study evaluating the role of oral anticoagulation is needed in this patients. This study will compare the efficacy and safety of non-vitamin K anticoagulants (apixaban) and no oral anticoagulation in patient with sinus rhythm one year after catheter ablation of AF.

CONDITIONS

Official Title

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

Who Can Participate

Age: 19Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • No recurrence of atrial fibrillation one year after catheter ablation of atrial fibrillation
  • CHA2DS2-VASc score 61;1 for males or 61;2 for females
  • Age between 19 and 80 years
  • Non-valvular atrial fibrillation
  • Consent to participate in the study
  • Ability to be followed after enrollment
Not Eligible

You will not qualify if you...

  • Severe liver or kidney dysfunction
  • Thyroid dysfunction
  • Pregnant or breastfeeding women
  • Malignant tumors that have not been completely cured
  • Severe structural heart disease
  • Predicted survival less than 12 months
  • Patients who do not understand or disagree with the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Severance Cardiovascular Hospital Yonsei University

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

B

Boyoung Joung, Ph.D

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here